Estorch M, Narula J, Flotats A, Marí C, Tembl A, Martín J C, del Valle Camacho M, Catafau A M, Serra-Grima R, Carrió I
Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Eur J Nucl Med. 2001 May;28(5):614-9. doi: 10.1007/s002590100510.
Perfusion imaging combined with pharmacological stress is the study of choice in patients with ischaemic heart disease who are incapable of exercising. Some medical conditions, however, can preclude the use of pharmacological stress. In these particular situations, availability of a diagnostic test which allows for the assessment of ischaemic territory at rest would be desirable. With the purpose of providing a marker of reversible ischaemia, we evaluated myocardial iodine-123 metaiodobenzylguanidine (MIBG) uptake in regions with fixed and reversible defects defined by exercise/rest perfusion study. Fifty-four male patients with ischaemic heart disease and previous myocardial infarction were studied by means of exercise/rest tetrofosmin and MIBG single-photon emission tomography (SPET). Regional tracer uptake was quantified and expressed as a percentage of maximum peak activity. Areas with denervated but perfused myocardium and areas with ischaemic myocardium were calculated. Regions with<75% of peak activity in the exercise perfusion study were divided into two groups according to whether the increase in peak activity in the respective rest study was >10% (reversible regional defect) or <10% (fixed regional defect). These percentages were compared with the percentages of the innervation study. The area of the innervation defect was significantly larger when the perfusion defect was reversible than when it was fixed. In regions with reversible perfusion defects, the size of the area of denervated but perfused myocardium was similar to the size of the area of ischaemic myocardium. In regions with reversible defects, the percentage of myocardial MIBG uptake was not significantly different from the percentage of tetrofosmin uptake at exercise, while it was significantly lower than the percentage of tetrofosmin uptake at rest. In regions with fixed defects, the percentage of myocardial MIBG uptake was significantly lower than the percentage of tetrofosmin uptake at exercise and at rest. In patients who developed angina during exercise test, the area of denervated but perfused myocardium was significantly larger than in patients without angina (4.1+/-2.4 vs 3.4+/-2.5, P=0.02). The same trend was observed with regard to the size of the innervation defect (8.6+/-2.4 vs 5.7+/-2.2, P=0.02). It is concluded that when the use of pharmacological stress is not possible in patients incapable of exercising, rest studies with MIBG combined with rest myocardial perfusion studies may be useful as a marker of reversible ischaemia.
灌注成像结合药物负荷试验是无法进行运动的缺血性心脏病患者的首选检查方法。然而,某些疾病可能会妨碍使用药物负荷试验。在这些特殊情况下,能够在静息状态下评估缺血区域的诊断性检查将是很有必要的。为了提供可逆性缺血的标志物,我们通过运动/静息灌注研究定义了固定和可逆性缺损区域,评估了心肌碘-123间碘苄胍(MIBG)摄取情况。对54例患有缺血性心脏病且既往有心肌梗死的男性患者进行了运动/静息替曲膦和MIBG单光子发射断层扫描(SPET)研究。对区域示踪剂摄取进行定量,并表示为最大峰值活性的百分比。计算去神经但灌注心肌的区域和缺血心肌的区域。运动灌注研究中峰值活性<75%的区域根据相应静息研究中峰值活性的增加是>10%(可逆性区域缺损)还是<10%(固定性区域缺损)分为两组。将这些百分比与神经支配研究的百分比进行比较。当灌注缺损为可逆性时,神经支配缺损区域明显大于固定性灌注缺损时。在有可逆性灌注缺损的区域,去神经但灌注心肌的区域大小与缺血心肌的区域大小相似。在有可逆性缺损的区域,运动时心肌MIBG摄取百分比与替曲膦摄取百分比无显著差异,而静息时则显著低于替曲膦摄取百分比。在有固定性缺损的区域,运动和静息时心肌MIBG摄取百分比均显著低于替曲膦摄取百分比。在运动试验中出现心绞痛的患者中,去神经但灌注心肌的区域明显大于无心绞痛的患者(4.1±2.4 vs 3.4±2.5,P = 0.02)。在神经支配缺损大小方面也观察到相同趋势(8.6±2.4 vs 5.7±2.2,P = 0.02)。得出的结论是,当无法对无法运动的患者使用药物负荷试验时,MIBG静息研究结合静息心肌灌注研究可能作为可逆性缺血的标志物是有用的。